Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 09:34pm US/Eastern
Recommend:
0

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
Recommend :
0
React to this article
Latest news
Date Title
<1m ago HEAT BIOLOGICS : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
<1m ago HARVEST NATURAL RESOURCES : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
<1m ago JOHN ARNOLD : Nhale, inc. - 10-q - management's discussion and analysis of financial condition and results of operations
<1m ago NORTHERN PROPERTY REIT : Announces Timing of 2014 Third Quarter Earnings
1m ago VWR : and Wayfair headline Thursday's IPOs
1m ago TELECOM ITALIA : net debt below 25 billion euros end year counting bond as equity
2m ago Motorcyclist killed in Paralimni
2m ago NEW YORK TIMES : to Webcast Third-Quarter 2014 Earnings Conference Call
2m ago Nakina and Wind River Collaborate to Deliver Carrier Class NFV Solutions
2m ago BELAIR CAPITAL PARTNERS INC. : Acquisition of Shares of Saratoga Electronic Solutions Inc.
Latest news
Advertisement
Hot News 
XAAR : To Slash Costs As It Lowers Revenue Guidance On China Weakness
BEOWULF MINING : To Contend Swedish Mine Ruling In Favour Of Reindeer
ORDINA : investigates Zembla claims: initial findings reveals no irregularities
REALD : Comments on Unsolicited Non-Binding Indication of Interest from Starboard
INTERQUEST : Recruitment in Tunbridge Wells highlighted in Recruitment International
Most Read News
12h ago TESLA MOTORS : Musk says 'about time to unveil the D and something else'
1d ago JANUS CAPITAL : Pimco Total Return Fund posts record $23.5 billion net outflow in September
1d ago JPMORGAN CHASE : to Present at the Bank of America Merrill Lynch Banking & Financial Services Conference
1d ago TOTAL SYSTEM SERVICES : Pimco Total Return Fund posts record $23.5 billion net outflow in September
1d ago CANADIAN PACIFIC RAILWAY : CP Rail looks to boost revenue to C$10 billion in 2018
Most recommended articles
1m ago TELECOM ITALIA : net debt below 25 billion euros end year counting bond as equity
5m ago Automotive industry has got its mojo back - Singh
8m ago ECB targets bundled-debt market to boost economy
10m ago Euro Remains in Clear Downtrend versus Swiss Franc
13m ago Boeing to raise monthly production of 737 jets to 52 in 2018
Dynamic quotes  
ON
| OFF